Vunakizumab-IL22, a Novel Fusion Protein, Promotes Intestinal Epithelial Repair and Protects against Gut Injury Induced by the Influenza Virus

Vunakizumab-IL22, a Novel Fusion Protein, Promotes Intestinal Epithelial Repair and Protects against Gut Injury Induced by the Influenza Virus

Secondary immune damage to the intestinal mucosa due to an influenza virus infection has gained the attention of investigators. The protection of the intestinal barrier is an effective means of improving the survival rate in cases of severe pneumonia. We developed a fusion protein, Vunakizumab-IL22(...

Full description

Bibliographic Details
Main Authors: Chenchen Shi, Chang Su, Lifeng Cen, Lei Han, Jianguo Tang, Zetian Wang, Xunlong Shi, Dianwen Ju, Yiou Cao, Haiyan Zhu
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Biomedicines
Subjects:
influenza A virus
Vunakizumab-IL22
intestinal barrier
gut–lung axis
dextran sulfate sodium
Online Access:https://www.mdpi.com/2227-9059/11/4/1160

Internet

https://www.mdpi.com/2227-9059/11/4/1160

Similar Items